Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study
For more information regarding our Privacy Policy, please review here
Exenatide, when combined with metformin, has been shown to significantly suppress the proliferation of breast cancer cells [104]
Given these benefits, GLP-1s are a powerful tool in the fight against obesity and metabolic dysfunction and have revolutionized treatments
The trials were originally met with limited enthusiasm since several extensive outcome trials had indicated that intensified diabetes therapy was not associated with cardiovascular benefit
Michele Green to assess and address the cause with a personalized treatment plan